CAPRICOR THERAPEUTICS, INC. (CAPR)
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Address
8840 WILSHIRE BLVD
BEVERLY HILLS, CA 90211
Founded
1996
Number of Employees
102
Website
http://www.capricor.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)